Knudsen, C.; Casewell, N.R.; Lomonte, B.; Gutiérrez, J.M.; Vaiyapuri, S.; Laustsen, A.H.
Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy. Toxins 2020, 12, 528.
https://doi.org/10.3390/toxins12090528
AMA Style
Knudsen C, Casewell NR, Lomonte B, Gutiérrez JM, Vaiyapuri S, Laustsen AH.
Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy. Toxins. 2020; 12(9):528.
https://doi.org/10.3390/toxins12090528
Chicago/Turabian Style
Knudsen, Cecilie, Nicholas R. Casewell, Bruno Lomonte, José MarÃa Gutiérrez, Sakthivel Vaiyapuri, and Andreas H. Laustsen.
2020. "Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy" Toxins 12, no. 9: 528.
https://doi.org/10.3390/toxins12090528
APA Style
Knudsen, C., Casewell, N. R., Lomonte, B., Gutiérrez, J. M., Vaiyapuri, S., & Laustsen, A. H.
(2020). Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy. Toxins, 12(9), 528.
https://doi.org/10.3390/toxins12090528
